Latanoprost Ophthalmic Suspension [Xelpros]
RxNorm 2056746
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2056746 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: latanoprost Ophthalmic Suspension [Xelpros].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDFPrescribable
Semantic Branded Drug Form (SBDF):
Latanoprost Ophthalmic Suspension [Xelpros]
(Atom ID: 10333364)
Patient Education
Latanoprost Ophthalmic
Latanoprost ophthalmic is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision) and ocular hypertension (a condition which causes increased pressure in the eye). Latanoprost is in a class of medications called prostaglandin analogs. It lowers pressure in the eye by increasing the flow of natural eye fluids out of the eye.
[Learn More]
* Please review the disclaimer below.